IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart Disease
Clinical trial NCT03105219 · WITHDRAWN
Trial details
- NCT number
- NCT03105219
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2021-05-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.